Marketing-authorisation holder
SFL Pharmaceuticals Deutschland GmbH
4 medicines in 3 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AUMSEQACompressa rivestita con film | Aumolertinib | Italy | Authorised | |
| Aumseqa | Aumolertinib | EU (EMA) | Authorised | 2026 |
| Aumseqa 55 mg filmomhulde tabletFilmomhulde tablet | Aumolertinib | Netherlands | Authorised | 2026 |
| Nyxthracis (previously Obiltoxaximab SFL) | Obiltoxaximab | EU (EMA) | Withdrawn | 2020 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 2 | 1 | 1 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | Companies |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 3
- Roles
- Authorisation holder